All news

Corvus Pharmaceuticals (CRVS) executive Arcara bought 4,500 shares for $50.5K at an average

Alpha Vantage · Quantisnow · · AI-summarised by FinFlash

Jeffrey Arcara, Chief Business Officer at Corvus Pharmaceuticals (CRVS), purchased 4,500 shares of the company's common stock for approximately $50.5K, at an average price of

Read original source

CRVS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.